A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors - Concepedia

Concepedia

Publication | Closed Access

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

249

Citations

37

References

2007

Year

Myrna Candelaria, Dolores Gallardo‐Rincón, Claudia Arce, Lucely Cetina, José Luis Aguilar-Ponce, Óscar Arrieta, Aurora González‐Fierro, Alma Chávez‐Blanco, Erik de la Cruz-Hernandez, Maria Fernanda Vieira Cunha Camargo,

Annals of Oncology

Chemotherapy ResistanceMedicinePharmacologyMagnesium ValproatePharmacotherapyRefractory Solid TumorsAnti-cancer AgentCancer TreatmentOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1